FDA plans to revoke approval of Makena, the only preterm birth reduction therapy
FDA plans to revoke approval of Makena, the only preterm birth reduction therapy… Continue reading
Standard Posts
Novel Drug Combination for Malignant Pleural Mesothelioma Approved by FDA
Novel Drug Combination for Malignant Pleural Mesothelioma Approved by … Continue reading
Setrusumab was granted Rare Pediatric Disease Designation by FDA
Setrusumab was granted Rare Pediatric Disease Designation by … Continue reading
Etrasimod for Ulcerative Colitis: Global Phase III trial by Arena Pharmaceuticals
Etrasimod for Ulcerative Colitis: Global Phase III trial by Arena Pharmaceuticals… Continue reading
